title: [What is the future for niacin after the AIM-HIGH study?].
authors.affiliation: Instytut Żywności i Żywienia, Warszawa.
authors.forename: Barbara
authors.initials: B
authors.lastname: Cybulska
authors.forename: Longina
authors.initials: L
authors.lastname: Kłosiewicz Latoszek
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008076:Cholesterol, HDL / Q000187:drug effects*; D008078:Cholesterol, LDL / Q000187:drug effects*; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000188:drug therapy*; D009525:Niacin / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D000960:Hypolipidemic Agents; D009525:Niacin